Subscribe to this collection to receive daily e-mail notification of new additions

	Title	Author(s)	Issue Date
	Detection of notable hepatitis B virus serologic activity after hepatitis B surface antigen seroclearance Proceeding/Conference:The International Liver Congress 2022	Wong, DKHInoue, TMak, LYFung, JCheung, KSMSeto, WKWTanaka, YYuen, RMF	2022
	Effects of the siRNA JNJ-3989 and/or the capsid assembly modulator (CAM-N) JNJ-6379 on viral markers of chronic hepatitis B (CHB): results from the REEF-1 study. Poster Presentation (SAT422) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Yuen, RMFAsselah, TJacobson, IMBrunetto, MJanssen, HTakehara, THou, JLKakuda8, TLambrecht, TKalmeijer, RGuinard-Azadian, CMayer, CJerzorwski, JVerbinnen, TLenz, OShukla, UBiermer, M	2022
	'The Evolving Therapeutic Landscape for Lupus Nephritis' Proceeding/Conference:at the Annual Scientific Meeting of Hong Kong Paediatric Nephrology Society, November 2022.	Chan, DTM	2022
	Longer treatment duration of monthly VIR-2218 results in deeper and more sustained reductions in hepatitis B surface antigen in participants with chronic hepatitis B infection. Oral Presentation (OS090) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Lim, YSYuen, RMFCloutier, DThanawala, VShen, LGupta, SVArizpe, ACathcart, AHwang, CGane, EJ	2022
	Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study Proceeding/Conference:Thyroid	Lee, CHPWOO, YCLui, TWD	2022
	Training, validation and testing of a multiscale three-dimensional deep learning algorithm in accurately diagnosing hepatocellular carcinoma on computed tomography. Oral Presentation (OS105) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Seto, WKWChiu, WHKLui, GZhou, CHENGCheng, HMWu, JShen, XPMak, LYHuang, JHLi, WKYuen, RMFYu, PLH	2022
	HBV PGRNA and DNA both rebound immediately following discontinuation of the core inhibitor vebicorvir despite continued nrti treatment in patients with HBeAg positive chronic hepatitis B virus infection: findings from a phase 2 open label study Proceeding/Conference:Oral presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology	Yuen, RMFMa, XLHassanein, TIKwo, PYMa, JLi, LKitrinos, KKnox, SJStamm, LMBae, HSulkowski, MSElkhashab, MAgarwal, K	2021
	EDP-514, a potent pangenotypic class II hepatitis B virus core inhibitor, demonstrates significant HBV DNA and HBV RNA reductions in a phase 1b study in viremic, chronic hepatitis B patients. Poster Presentation (SAT393) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Yuen, RMFChuang, W-LPeng, C-YPeng, R W-JSu, W-WChang, T-TChen, C-YHsu, Y-CDe Rosa La, GAhmad, ALuo, EConery, AAdda, N	2022
	Safety, pharmacokinetics, and antiviral activity of the class II capsid assembly modulator ALG-000184 in subjects with chronic hepatitis B. Poster Presentation (SAT835) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Yuen, RMFAgarwal, KGane, EJJucov, ASchwabe, CNiu, JQHou, JLLe, KMassetto8, BWestland, CZhang, QLLai, FVenkatraman, NBlatt, LLin, T-IChanda, SChanda, MFry, J	2022
	Predictors of HBsAg loss after cessation of nucleo (s)tide analogue therapy in asian patients with low HBsAg levels. Poster Presentation (SAT344) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Sonneveld1, MChiu, SMPark, JYKaewdech, ASeto, WKWTanaka, YCarey, IPapatheodoridi, Mvan Bömmel, FBrakenhoff, SBerg, TZoulim, FAhn, SHDalekos, GErler, NHoener zu Siederdissen, CWedemeyer1, HCornberg, MYuen, RMFAgarwa, KBoonstra, AButi, MPiratvisuth, TPapatheodoridis8, GChen, C-HMaasoumy, B	2022
	Characterisation of baseline complement values in patients with chronic hepatitis B virus infection in the phase IIb B-clear study. Poster Presentation (THU390) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Cremer, JRichards, ALukic, TLim, SGPlesniak, RTsuji, KJanssen, HPojoga, CPopescu, CPAsselah, TPetrova, DYim, HJDiaconescu, GHeo, JWong, AJanczewska, ERizzardini, GYuen, RMFQuinn, GBharania, PPaff, MTheodore, D	2022
	Characteristics and renal function in patients with chronic hepatitis B virus infection: baseline data from the phase 2b BClear study. Poster Presentation (THU389) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Lim, SGPlesniak, RTsuji, KJanssen, HPojoga, CGadano, APopescu, CPAsselah, TPetrova, DYim, HJDiaconescu, GHeo, JWong, AJanczewska, EYuen, RMFCremer, JLukic, TKendrick, SElston, RQuinn, GBharania, PCampbell, FPaff, MTheodore, D	2022
	Decorin deficiency exacerbates peritoneal inflammation and fibrosis in a murine model of peritoneal dialysis Proceeding/Conference:World Congress of Nephrology 2022	Mok, CWLOH, IKwan, CYAIozzo, RChan, DTMYung, SSY	2022
	Liver fibrosis burden determines risk of hepatocellular carcinoma among patients with hepatitis B surface antigen seroclearance. Poster Presentation (THU360) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Mak, LYCheung, KSMHui, WHRWong, DKHFung, JYYYuen, RMFSeto, WKW	2022
	Screening, linkage to care and treatment of chronic hepatitis C infection in high-risk populations in Hong Kong Proceeding/Conference:Hepatology	Mak, LYTo, WPTsui, VHui, KYWu, TKo, KLWong, DKHWong, SYLiu, KSHSeto, WKWYuen, RMF	2022
	Suboptimal glycemic control is associated with adverse clinical outcomes in patients with chronic hepatitis B and diabetes mellitus Proceeding/Conference:The International Liver Congress 2022	Mak, LYHui, WHRCheung, KSMWong, DKHFung, JYuen, RMFSeto, WKW	2022
	The Independent Association of TSH and Free Triiodothyronine Levels With Lymphocyte Counts Among COVID-19 Patients Proceeding/Conference:Frontiers in Endocrinology	Lui, TWDLee, CHPCHOW, WSLEE, ACHTan, KCBWOO, YCHung, FNILam, KSL	2022
	A Territory-Wide Study of SGLT2 Inhibitor-Associated Post-Operative Diabetic Ketoacidosis in Type 2 Diabetes Patients Proceeding/Conference:American Diabetes Association 82nd Scientific Sessions, Hybrid, 3-7 June 2022	Lui, TWDTan, KCBLee, CHPWOO, YC	2022
	Evaluation of the impact of COVID-19 vaccines on thyroid function and autoimmunity and the potential influence of pre-existing thyroid autoimmunity on neutralizing antibody responses Proceeding/Conference:ENDO 2022, Hybrid, 11-14 June 2022	Lui, TWDLee, CHPCheung, YYMAK, HCFong, HYWOO, YCLEE, ACHHung, FNITan, KCBLam, KSL	2022
	Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients Proceeding/Conference:10th Seoul International Congress of Endocrinology and Metabolism, Hybrid, 27-29 October 2022	Lui, TWDLee, CHPWOO, YC	2022